







Seeing really is believing
- Nearly 9 out of 10 study patients did not require glasses2
- Excellent image quality at all distances, under any lighting condition1
- Over 94% of study patients would choose TECNIS Multifocal IOL again2

Exceptionally high patient satisfaction
- Over 94% of patients achieved simultaneous 20/25 or better distance and 20/32 or better near visual acuity at 4-6 months (binocular vision, photopic conditions, distance-corrected, N=294)2
- 93.8% of bilaterally implanted patients functioned comfortably without glasses at all distances—near, intermediate, and far—at 1 year (N=112)2
- 94.6% of bilaterally implanted patients queried at 1 year would choose TECNIS Multifocal IOL again (N=112)2
Peak performance
- Low-light reading speed is twice as fast compared with Acrysof® ReSTOR® IOL3
- Delivers a predictable and consistent full range of vision in all light conditions1
- Nearly 9 out of 10 patients NEVER wear glasses2
Optimized design
- Aspheric anterior surface corrects spherical aberration to essentially zero1
- Fully diffractive posterior surface for complete pupil independence1
- Proprietary non-apodized optic and clear hydrophobic acrylic for outstanding image quality1
Back to top



Data from two US clinical trials (347 TECNIS Multifocal subjects, 306 bilaterally implanted) demonstrate that the TECNIS Multifocal IOL provides exceptional performance and extremely high patient satisfaction compared with the Acrysof® ReSTOR® IOL.2,4
The TECNIS Multifocal IOL consistently delivers high-quality vision with few reports of severe halos or glare.2
TECNIS® Multifocal IOL vs. Acrysof® ReSTOR® IOL

Back to top



The TECNIS Multifocal IOL is the only full-surface diffractive aspheric IOL. It enables patients to function comfortably without glasses at near, intermediate, and far distances2 and provides superior functional near vision as demonstrated by reading speed comparisons.2,3
Mean Binocular Visual Acuity at 4-6 Months2

Reading Speed at 6 Weeks3

Ability to Function Comfortably
Without Glasses at 1 Year2

Back to top


References:
1. Terwee T, Weeber H, van der Mooren M, Piers P. Visualization of the retinal image in an eye model with spherical and aspheric, diffractive, and refractive multifocal intraocular lenses.
J Refract Surg. 2008;24:223-232. 2. TECNIS Multifocal Foldable Acrylic Intraocular Lens
package insert. Santa Ana, CA: Advanced Medical Optics, Inc. 3. Hütz WW, Eckhardt HB, Röhrig B, Grolmus R. Reading ability with three multifocal intraocular lens models.
J Cataract Refract Surg. 2006;32(12):2015-2021. 4. AcrySof ReSTOR apodized diffractive IOL
package insert. Fort Worth, TX: Alcon, Inc.
Important Safety Information – TECNIS Multifocal IOL
Caution: Federal law restricts this device to sale by or on the order of a physician.
Indications: TECNIS® Multifocal intraocular lenses are indicated for primary implantation for the visual correction of aphakia in adult patients with and without presbyopia in whom a cataractous lens has been removed by phacoemulsification and who desire near, intermediate, and distance vision with increased spectacle independence. The intraocular lenses are intended to be placed in the capsular bag.
Warnings: Physicians considering lens implantation under any of the conditions described in the Directions for Use labeling should weigh the potential risk/benefit ratio prior to implanting a lens. Some visual effects associated with multifocal IOLs may be expected because of the superposition of focused and unfocused images. These may include a perception of halos/glare around lights under nighttime conditions. It is expected that, in a small percentage of patients, the observation of such phenomena will be annoying and may be perceived as a hindrance, particularly in low illumination conditions. On rare occasions these visual effects may be significant enough that the patient will request removal of the multifocal IOL. Under low-contrast conditions, contrast sensitivity is reduced with a multifocal lens compared to a monofocal lens. Therefore, patients with multifocal lenses should exercise caution when driving at night or in poor visibility conditions. Patients with a predicted postoperative astigmatism >1.0D may not be suitable candidates for multifocal IOL implantation since they may not fully benefit from a multifocal IOL in terms of potential spectacle independence.
Precautions: The central one millimeter area of the lens creates a far image focus, therefore patients with abnormally small pupils (~1mm) should achieve, at a minimum, the prescribed distance vision under photopic conditions; however, because this multifocal design has not been tested in patients with abnormally small pupils, it is unclear whether such patients will derive any near vision benefit. Autorefractors may not provide optimal postoperative refraction of multifocal patients; manual refraction is strongly recommended. In contact lens wearers, surgeons should establish corneal stability without contact lenses prior to determining IOL power. Care should be taken when performing wavefront measurements as two different wavefronts are produced (one will be in focus (either far or near) and the other wavefront will be out of focus); therefore incorrect interpretation of the wavefront measurements is possible. The long-term effects of intraocular lens implantation have not been determined; therefore implant patients should be monitored postoperatively on a regular basis. Secondary glaucoma has been reported occasionally in patients with controlled glaucoma who received lens implants. The intraocular pressure of implant patients with glaucoma should be carefully monitored postoperatively. Do not resterilize or autoclave. Use only sterile irrigating solutions such as balanced salt solution or sterile normal saline. Do not store in direct sunlight or over 45°C. Emmetropia should be targeted as this lens is designed for optimum visual performance when emmetropia is achieved. Care should be taken to achieve centration.
Adverse Events: The most frequently reported adverse event that occurred during the clinical trial of the TECNIS® Multifocal lens was macular edema, which occurred at a rate of 2.6%. Other reported reactions occurring in 0.3 – 1.2% of patients were hypopyon, endophthalmitis, and secondary surgical intervention (including biometry error, retinal repair, iris prolapse/wound repair, trabeculectomy, lens repositioning, and patient dissatisfaction).
Attention: Reference the Directions for Use for a complete listing of indications, warnings, and precautions.